1. Kyoto University Research Information Repository
  2. 060　医学研究科・医学部・医学部附属病院
  3. 泌尿器科紀要
  4. Vol.12 No.3
ダウンロード数: 695

    このアイテムの引用には次の識別子を使用してください: http://hdl.handle.net/2433/112920
このアイテムのファイル:
ファイル 記述 サイズフォーマット 
12_306.pdf765.85 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド値言語
dc.contributor.author稲田, 務ja
dc.contributor.author酒徳, 治三郎ja
dc.contributor.author本郷, 美弥ja
dc.contributor.author蛭多, 量令ja
dc.contributor.author清水, 幸夫ja
dc.contributor.alternativeINADA, Tsutomuen
dc.contributor.alternativeSAKATOKU, Jisaburoen
dc.contributor.alternativeHONGO, Haruyaen
dc.contributor.alternativeEBISUTA, Kazuyoshien
dc.contributor.alternativeSHIMIZU, Yukioen
dc.date.accessioned2010-05-24T01:59:18Z-
dc.date.available2010-05-24T01:59:18Z-
dc.date.issued1966-03-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/112920-
dc.description.abstractOral administration of TAB (BCP) (5-n-butyl-1-cyclohexyl-2, 4, 6-trioxoperhydropyrimidine) was attempted in 14 patients undergone urological operations and 21 patients with urogenital infections in order to study its antiedematous and antiinflammatory effects. Sinc the number of cases were inadequate to evaluate a difinite effectiveness of the drug, it is necessary to repeat the study with different dosage and duration of administration in selected cases to obtain conclusive informations on the drug. For 3 cases having normal renal functions, blood conc e ntration and urinary excretion were determined after administration of BCP at the dose of 600 mg per day, In 2 to 3 days after initiation of the drug, blood concentration reached to nearly plateau lelvel of 7 to 11 mg%. Almost complete disapperance was recognized in 4 days after cessation of administration. About 15 % to 20 % of given dose excreted as free and conjugated types of BCP.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher京都大学医学部泌尿器科学教室ja
dc.publisher.alternativeDepartment of Urology, Faculty of Medicine, Kyoto Univeersityen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAnti-Inflammatory Agents/therapeutic useen
dc.subjectCystitis/drug therapyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPostoperative Complicationsen
dc.subjectPyrimidines/therapeutic useen
dc.subjectUrologic Diseases/surgeryen
dc.subject.ndc494.9-
dc.title泌尿器科領域におけるTAB(BCP)の使用経験ja
dc.title.alternativeUse of TAB (BCP) in the field of urologyen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume12-
dc.identifier.issue3-
dc.identifier.spage306-
dc.identifier.epage317-
dc.textversionpublisher-
dc.sortkey09-
dc.address京都大学医学部泌尿器科教室ja
dc.address京都大学医学部泌尿器科教室ja
dc.address京都大学医学部泌尿器科教室ja
dc.address京都大学医学部泌尿器科教室ja
dc.address京都大学医学部泌尿器科教室ja
dc.address.alternativethe Department of Urology, Faculty of Medicine, Kyoto Universityen
dc.identifier.pmid6006675-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.12 No.3

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。